Sign Our Open Letter to AstraZeneca June 7, 2024
Urgent Appeal for the Introduction of Symbicort Turbuhaler DPI to the U.S.
We, as health and sustainability professionals and organizations concerned about the impact of the accelerating climate crisis on public health, are writing to AstraZeneca with a plea to make their Symbicort Turbuhaler dry powder inhaler (DPI) available in the United States as soon as possible.
You can read the full letter here.
Deadline to sign: July 1
More Action Alert
How do trees and green spaces enhance our health?
Wynne Armand, MD, Greater Boston PSR Board Member | Harvard Health Publishing Trees and their leafy canopy provide shade that helps to prevent urban heat...
Why is the US locking down for climate change?
Brita Lundberg, MD | CommonWealth Beacon Our children aren’t playing outside because it’s 118 degrees Fahrenheit or there is fire at the door or they...
The term ‘turf’ is misleading
GBPSR's Philip Landrigan, MD; Sydney Engel; and Brita Lundberg, MD | CommonWealth Beacon This material has no relationship to actual turf or grass. It is...